Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines. - Wikidata - wikimedia - TriplyDB

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.

http://www.wikidata.org/entity/Q37379398

about

Trial Watch: Peptide-based anticancer vaccines.Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma.Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workers Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.Immune effectors required for the therapeutic activity of vorinostat.Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies.Cancer: Antibodies regulate antitumour immunity.

P2860

Q34483345-A36F2C15-ACAA-4EDF-A390-4CF345857D39 Q34616067-05AE453A-808E-4F68-A471-CAA307A172E8 Q36821138-2725D54B-D7AC-442D-84CC-AC082B91D3B9 Q37340661-1BF00B15-4821-4B49-99E1-36B2095A9CB1 Q37631325-FEC6AC48-93CC-46E0-87C0-87DF465BE0EB Q37634941-CEBEAE0D-C2BE-49F4-82A9-D376F0718749 Q37695311-9F0CDDDF-4C8C-4764-BD50-C9A858DA6C5B Q41871572-F9B0421C-C786-4214-8382-8C65815A3C8A Q47557087-31C32156-21FC-4129-B3A1-0DBAE5322962 Q53524931-FEFFA5AA-AB1C-4F0B-B881-F4CE1E1236D4

P2860

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.

http://www.wikidata.org/entity/Q37379398

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Contribution of humoral immune ...... ts mediated by anthracyclines.

@en

Contribution of humoral immune ...... ts mediated by anthracyclines.

@nl

type

label

Contribution of humoral immune ...... ts mediated by anthracyclines.

@en

Contribution of humoral immune ...... ts mediated by anthracyclines.

@nl

prefLabel

Contribution of humoral immune ...... ts mediated by anthracyclines.

@en

Contribution of humoral immune ...... ts mediated by anthracyclines.

@nl

P1433

Q37379398-E39C649E-F696-4868-8767-9FC16179D4A5

P1476

Q37379398-7458ECD8-4547-41C5-8141-B601939FA923

P2093

Q37379398-E3CD7E22-DC3A-4C30-9EA1-07B43284C05A

Q37379398-FDB7A9B3-57FD-4E1C-AF74-0AF8ECC9184D

P2860

Q37379398-00A3EDDF-1B31-47B7-B46A-A9D62AF81CDD

Q37379398-0338F49C-6457-431A-B0B6-EFA866D00E88

Q37379398-199326F7-AC5B-4BF5-83B2-74501F1D15BF

Q37379398-1C68AEE5-FA20-41DB-AAB1-7BE372531024

Q37379398-1DDC99BF-9CD0-4DA8-8B8F-9A5D265CB03B

Q37379398-2564ADE8-ADBD-4363-BA91-42B8FA6F0305

Q37379398-258EE6D2-75C2-40B9-B09F-C7F55917641B

Q37379398-269405F1-C5EF-46FF-9996-4DDE2FB96721

Q37379398-2A2A57B7-62FC-46FF-966A-9D4CE6F75374

Q37379398-2F42250B-120E-40AA-ABF3-3397D0533D59

P2888

Q37379398-5F8ECE56-5135-410F-8249-D45CDDB1E731

P304

Q37379398-3976F7C2-44AD-4501-A7F0-00505B961251

P31

Q37379398-C02F9035-1765-4985-BC37-AB705743392B

P356

Q37379398-232E6182-EC55-4C75-B113-D885729D3886

P433

Q37379398-FCF505F6-8394-4A3F-99DA-65EFF09AE7BB

P478

Q37379398-BD39800D-6E17-48C1-96FC-E4FC7AEFEC4A

P50

Q37379398-2B8A15D6-502E-4B5F-AE47-D8EF872E31A1

Q37379398-2C40E43C-1084-41A0-8A4A-A367D09EF5E8

Q37379398-3AAF801A-E4E9-4FDD-81EF-1A2F460714E5

Q37379398-442BF326-3DC8-40EE-8DC2-DFE1F34BD90D

Q37379398-63719BD8-6B4B-4761-81A8-E12D8C5B9E9E

Q37379398-D670500D-A710-4E31-9865-DB35DFC99E3F

Q37379398-EBC7B2A5-2026-4188-B0E6-F56CC058DB53

Q37379398-EEB36DFC-D25F-4F1B-AFDA-6FFB170AE56E

Q37379398-F735F4B7-D369-45BE-9C81-DD55219B635B

Q37379398-FA8D7204-5F3A-40DD-9E8D-539308C889FA

P577

Q37379398-0CE71576-B9CD-46D5-A8D9-FB38EC4CEA10

P5875

Q37379398-9B1D08CF-FAA0-4C7B-8986-879DA6AB547C

P6179

Q37379398-187CFB78-66A6-4A30-9F13-6397CFB72A29

P698

Q37379398-C1AE1E76-D277-4B15-9B21-7A759A2CA1AF

P932

Q37379398-72BD2186-3FFF-4BE0-90A4-E912B7997380

P356

P1433

Cell Death & Differentiation

P1476

Contribution of humoral immune ...... ts mediated by anthracyclines.

@en

P2093

D Sanchez

http://www.w3.org/2001/XMLSchema#string

P Bruhns

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.

B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection

Mincle is an ITAM-coupled activating receptor that senses damaged cells

FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation

Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

Taking dendritic cells into medicine

P2888

P304

50-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDD.2013.60

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

Véronique Minard-Colin

Laetitia Aymeric

Takahiro Yamazaki

P577

2013-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237070545

http://www.w3.org/2001/XMLSchema#string

P6179

1048061865

http://www.w3.org/2001/XMLSchema#string

P698

23744294

http://www.w3.org/2001/XMLSchema#string

P932

3857618

http://www.w3.org/2001/XMLSchema#string